These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38401871)

  • 1. An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.
    Wong CYJ; Baldelli A; Tietz O; van der Hoven J; Suman J; Ong HX; Traini D
    Int J Pharm; 2024 Apr; 654():123922. PubMed ID: 38401871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
    Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
    Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery systems from nose to brain.
    Misra A; Kher G
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and physiological factors influencing CNS delivery upon intranasal administration.
    Vyas TK; Tiwari SB; Amiji MM
    Crit Rev Ther Drug Carrier Syst; 2006; 23(4):319-47. PubMed ID: 17341201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile Nanoparticulate Systems as a Prosperous Platform for Targeted Nose-Brain Drug Delivery.
    Taha E; Shetta A; Nour SA; Naguib MJ; Mamdouh W
    Mol Pharm; 2024 Mar; 21(3):999-1014. PubMed ID: 38329097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route.
    Ghosh A; Majie A; Karmakar V; Chatterjee K; Chakraborty S; Pandey M; Jain N; Roy Sarkar S; Nair AB; Gorain B
    AAPS PharmSciTech; 2024 May; 25(5):96. PubMed ID: 38710855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to facilitate or block nose-to-brain drug delivery.
    Martins PP; Smyth HDC; Cui Z
    Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and ex vivo experimental models for evaluation of intranasal systemic drug delivery as well as direct nose-to-brain drug delivery.
    Haasbroek-Pheiffer A; Van Niekerk S; Van der Kooy F; Cloete T; Steenekamp J; Hamman J
    Biopharm Drug Dispos; 2023 Feb; 44(1):94-112. PubMed ID: 36736328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
    Scherließ R
    Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies.
    Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK
    J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal drug delivery for brain targeting.
    Vyas TK; Shahiwala A; Marathe S; Misra A
    Curr Drug Deliv; 2005 Apr; 2(2):165-75. PubMed ID: 16305417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing regional drug delivery within the nasal airways.
    Chen J; Finlay WH; Vehring R; Martin AR
    Expert Opin Drug Deliv; 2024 Apr; 21(4):537-551. PubMed ID: 38568159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
    Jiang Y; Li Y; Liu X
    Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies.
    Du L; Chen L; Liu F; Wang W; Huang H
    Int Rev Neurobiol; 2023; 171():255-297. PubMed ID: 37783558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
    Shah B; Khunt D; Misra M; Padh H
    Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation considerations for improving intranasal delivery of CNS acting therapeutics.
    Patel D; Thakkar H
    Ther Deliv; 2022 Jul; 13(7):371-381. PubMed ID: 36416617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.